Seres Therapeutics
MCRB
MCRB
102 hedge funds and large institutions have $127M invested in Seres Therapeutics in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 42 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less capital invested
Capital invested by funds: $256M → $127M (-$128M)
65% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 49
Holders
102
Holding in Top 10
1
Calls
$683K
Puts
$314K
Top Buyers
| 1 | +$3.25M | |
| 2 | +$2.51M | |
| 3 | +$2.01M | |
| 4 |
Morgan Stanley
New York
|
+$1.96M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.63M |
Top Sellers
| 1 | -$21.4M | |
| 2 | -$10.7M | |
| 3 | -$6.7M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$5.95M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.33M |